C

Omnicell, Inc. OMCL

$37.75 $0.651.75% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$36.60$37.83
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

OMCL Rating

Reward
Risk

OMCL Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

OMCL Company Overview

Omnicell, Inc. is a healthcare technology and automation company focused on medication management solutions for hospitals, health systems, post-acute care facilities, and pharmacies. The company operates primarily within the healthcare technology, pharmacy automation, and medication adherence industries. Omnicell’s core offerings include automated dispensing systems, medication management software, pharmacy robotics, intravenous compounding technologies, specialty pharmacy services, and analytics platforms designed to improve medication safety, operational efficiency, and regulatory compliance across healthcare environments.

The company’s primary revenue drivers include sales and servicing of automated medication dispensing systems, subscription-based software and cloud platforms, consumable products, and pharmacy-related services. Omnicell serves acute care hospitals, health systems, retail and specialty pharmacies, and long-term care providers primarily in the United States, while also maintaining operations in selected international markets. A major component of the company’s strategic positioning is its “Autonomous Pharmacy” vision, which integrates software, robotics, and data analytics to automate medication workflows across care settings. Founded in 1992, Omnicell expanded from automated dispensing cabinets into broader pharmacy automation and software solutions through internal development and acquisitions, including the acquisitions of Aesynt, Talyst, and ReCept Holdings.

Data compiled by narrative technology. May contain errors.
Sector

OMCL Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

OMCL Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

OMCL Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

OMCL Price History

Loading...
52-Week Range33% of range
Current
$37.75
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

OMCL Valuation

Market Cap
Market Cap Rank
#5,851
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

OMCL Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

OMCL Corporate Info

Phone Number
877 415 9990
Address
4220 North Freeway
Fort Worth, TX 76137
Country
Year Founded

OMCL Filings

Filing Date
Wednesday, August 5, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

OMCL Headlines

9/16/2026 - Zacks Investment Research